Tutorials › Statistical Genetics › Association In Repetitive And Low-Mappability Regions

Structural Variants and Copy Number · Tutorial 491 of 989

Association In Repetitive And Low-Mappability Regions

Learn to recognize when genomic sequence properties can undermine structural-variant calls and decide whether a region is suitable for association analysis.

Advanced 10 min read

What You'll Learn

  • Explain how segmental duplications, repeats, and ambiguous read alignment can generate artifactual structural-variant evidence
  • Distinguish a region’s apparent call rate from its ability to support reliable genotype calls
  • Calculate and interpret a simple read-mappability summary
  • Show how group-specific false-positive rates can produce an apparent association when true carrier prevalence is equal
  • Evaluate region-specific safeguards, including matched callability, read-level review, and orthogonal validation
  • Identify when excluding a region or withholding association testing is more defensible than applying an ordinary filter

Why Region Properties Matter

A structural-variant association test can be calculated correctly and still be misleading if the calls entering it are unreliable. This risk is especially important in segmental duplications and other repetitive sequence, where reads from one genomic copy can align to another. A caller may then interpret misplaced reads, apparent read-depth changes, or misleading breakpoint evidence as a deletion, duplication, or other structural variant.

The key question for this tutorial is not simply whether a variant passes a general quality filter. It is whether the particular genomic region can support reliable, comparable calls in the samples being tested. Region properties affect read placement and therefore can affect call sensitivity, false-positive rates, and the fraction of samples that can be called at all.

Definition: Mappability describes how readily a sequence read arising from a genomic location can be assigned to that location rather than to another plausible location in the reference genome. A region has low mappability when many reads from it cannot be placed uniquely or confidently. Mappability depends on factors including read length, sequencing technology, reference sequence, and alignment method; it is not an invariant property with one universal threshold.

How Repetitive Sequence Can Distort Calls

A segmental duplication is a genomic region that has a substantially similar copy elsewhere in the genome. Repetitive sequence can also occur in many copies, sometimes over shorter stretches. If reads from similar copies are difficult to distinguish, an aligner may place a read at the wrong copy, assign it low mapping quality, or leave it unmapped. Structural-variant callers use patterns such as read depth, discordant read pairs, and split reads; ambiguous placement can distort each of these signals.

  • Read depth: reads from a similar copy may accumulate at the wrong locus, making apparent depth too high. Reads that fail to map may instead make depth appear too low. Either pattern can resemble a copy-number change.
  • Breakpoint evidence: a read spanning a repeated sequence can be split or aligned across similar copies in a misleading way. The resulting apparent breakpoint may not correspond to a true rearrangement at that location.
  • Discordant pairs: reads from different copies can be assigned to positions that imply an unexpected distance or orientation, resembling evidence for a structural variant.
  • Reference limitations: missing, collapsed, or imperfectly represented sequence can make the alignment problem worse. A call can appear precise in genomic coordinates even when the underlying reads do not distinguish the locus reliably.

These problems do not mean that genuine structural variants cannot occur in repetitive regions. They mean that the evidence must be assessed in light of the region’s sequence properties. A high-quality-looking call from a difficult region is not automatically reliable, and a low call rate may reflect lack of information rather than absence of the variant.

Worked Example: Interpreting a Simple Mappability Summary

Suppose a hypothetical 10-kilobase candidate region is assessed using 1,000 reads from a sequencing assay. Of these, 620 are assigned uniquely to the region, 180 have ambiguous placements, and 200 are unmapped. What does this summary tell us?

The fraction of reads assigned uniquely is:

$$ \frac{620}{1{,}000}=0.620 $$

Thus, in this hypothetical read set, 62.0% of the reads are uniquely assigned to the region. The ambiguous fraction is \(180/1{,}000=18.0\%\), and the unmapped fraction is \(200/1{,}000=20.0\%\). Together, 38.0% of reads do not provide a unique placement.

This is a warning that read placement may be problematic, not a universal pass-or-fail result. The summary alone does not establish whether a structural-variant call is false: its interpretation depends on the assay, read length, alignment method, and the call’s supporting evidence. It does justify closer review of locus specificity and whether samples have comparable information at this region.

Region-Specific Assessment Before Testing

Before association testing, assess the region that contains the candidate event, rather than assuming that a general variant-level filter resolves mapping ambiguity. A practical assessment brings together reference annotation, read-level evidence, and sample-level callability. No single statistic can replace these checks.

1
Characterize the sequence.
Determine whether the event overlaps segmental duplications, repetitive elements, or other regions with poor unique sequence. Record the source and resolution of the annotation, because different references and read lengths may yield different assessments.
2
Review the evidence for the event.
Check whether supporting reads distinguish the proposed locus from similar copies. Examine mapping quality, read-depth patterns, breakpoint support, and whether evidence is consistent across samples. A caller’s output coordinates are not themselves proof of locus-specific support.
3
Assess callability by sample and group.
Establish which samples have enough usable information to make a genotype call. Compare callability between association groups and across sequencing batches. A sample that cannot be called must not automatically be coded as a noncarrier.
4
Choose a defensible analysis decision.
Depending on the evidence, retain the event with suitable region-specific safeguards, seek independent validation, or exclude the region from association testing. State the decision and its basis before interpreting an association result.

The criteria used in this process should be appropriate to the assay and specified without choosing them to obtain a desired association result. A fixed mapping-quality or unique-read threshold cannot be recommended for every platform and locus. If a region cannot distinguish copies well enough to support reliable calls, applying a more stringent version of an ordinary variant filter may not solve the underlying problem.

Why Differential Error Can Create an Association

A central concern is that call errors may differ between the groups being compared. For example, cases and controls may have been sequenced in different batches, or may differ in read quality. If a difficult region has more false-positive calls in one group, the observed carrier proportions can differ even when the true carrier proportions are equal.

Let \(p_g\) be the true carrier proportion in group \(g\), \(Se_g\) the probability that a true carrier is called positive, and \(f_g\) the probability that a true noncarrier is called positive. The observed positive-call proportion \(q_g\) follows by conditioning on true carrier status:

$$ q_g=P(\text{positive call}\mid g) =Se_g p_g+f_g(1-p_g) $$

The first term is the proportion of the group that consists of true carriers who are detected; the second is the proportion of true noncarriers who receive false-positive calls. If the true carrier proportions are equal but the false-positive rates differ, the observed proportions can still differ. This is why comparable region-specific calling matters for association testing.

Worked Example: A Group Difference From Unequal False-Positive Rates

Consider a hypothetical study with 200 cases and 200 controls. In each group, 4 people are true carriers, so the true carrier proportion is \(4/200=0.020\). Suppose the assay detects 3 of the 4 true carriers in each group. Because the region is difficult to map and the groups were processed under different conditions, it also produces 17 false-positive calls among the 196 noncarriers in cases, but 2 among the 196 noncarriers in controls.

The observed positive calls are \(3+17=20\) in cases and \(3+2=5\) in controls. The observed carrier proportions are therefore:

$$ \hat{p}_{\text{cases}}=\frac{20}{200}=0.100, \qquad \hat{p}_{\text{controls}}=\frac{5}{200}=0.025 $$

The corresponding observed odds ratio is:

$$ \widehat{OR} =\frac{20/180}{5/195} =\frac{20\times195}{180\times5} =4.333 $$

The observed calls suggest higher carrier odds in cases, even though the true carrier proportions were set equal. The false-positive rates among noncarriers are \(17/196=0.0867\) in cases and \(2/196=0.0102\) in controls. This calculation does not show that any particular association is artifactual; it demonstrates how group-specific calling errors can generate an apparent difference. An association statistic cannot correct for an unrecognized difference in call reliability.

Callability Is Not the Same as Genotype

A genotype or dosage summarizes the inferred structural-variant state. Callability concerns whether the available data support assigning that state for a particular sample. In a repetitive region, some samples may have too little uniquely placed evidence for a confident call. Treating those samples as reference or noncarrier samples changes the analysis rather than merely handling missing information.

Callability should be examined separately by case-control group and, where relevant, by sequencing batch or other technical group. A similar overall call rate can conceal an imbalance within a subgroup, while a difference in call rate can signal that the groups are not being compared on equally informative data. If callability depends on phenotype group, a simple analysis restricted to called genotypes may also be biased; the reason for missing calls matters.

Worked Example: A Call-Rate Imbalance at a Candidate Region

In a hypothetical study of 200 cases and 200 controls, a candidate region is callable for 160 cases and 190 controls. Among callable samples, 12 cases and 8 controls are called as carriers. A pre-specified study protocol requires at least 90% callability in each group for this region to be considered for association analysis.

The callability proportions are:

$$ \frac{160}{200}=0.800 \quad\text{for cases},\qquad \frac{190}{200}=0.950 \quad\text{for controls} $$

Case callability is 80.0%, below the protocol’s 90% requirement; control callability is 95.0%. Among called samples, the carrier proportions are \(12/160=0.0750\) and \(8/190=0.0421\). If those called samples are treated as a complete comparison, the resulting odds ratio is:

$$ \widehat{OR} =\frac{12/148}{8/182} =\frac{12\times182}{148\times8} =1.845 $$

This number describes the comparison among the samples with calls, but the protocol’s callability requirement is not met in cases. The 40 uncalled cases cannot be assumed to be noncarriers, and the observed odds ratio should not be presented as an adequately supported association estimate under this protocol. The appropriate response is to investigate why the region is less callable in cases and, if the imbalance cannot be resolved, withhold the association test or exclude the region according to the pre-specified analysis plan.

Safeguards and Their Limits

Safeguards should address the specific failure mode, not simply add more filtering. Useful checks include verifying that supporting reads are locus-specific, inspecting coverage and breakpoint evidence, and comparing these features across groups. When a region is important to the scientific question, independent evidence from an assay with different measurement properties can help establish whether the event is real. Any validation should target the same event and genomic locus, rather than merely confirming that a related copy exists.

For the association analysis, document how ambiguous or uncallable samples are handled and check that the rule is applied consistently. If cases and controls were processed in separate batches, region-level callability and evidence should be examined within those batches as well as overall. Statistical adjustment for a batch label is not a substitute for reliable measurement when batch and phenotype group are inseparable.

Possible decisions include retaining a well-supported event with adequate, comparable calls; obtaining additional locus-specific validation; or excluding the region from the association analysis. Exclusion can be scientifically preferable to reporting a precise estimate from calls that do not reliably identify the locus. The decision should reflect the evidence and analysis plan, not the direction or significance of the observed association.

Common Mistake

  • Wrong reasoning: “The variant passed the caller’s quality filter, so its genotypes are reliable enough to test.”
  • Correction: A caller’s filter does not necessarily resolve ambiguity caused by similar genomic copies. Assess whether the reads identify the locus, whether samples are comparably callable, and whether the evidence is consistent across the groups being compared.
  • Wrong reasoning: “A sample without a call is a noncarrier.”
  • Correction: A missing or uncallable genotype is not evidence of the reference state. Treating it as a noncarrier can distort carrier proportions, particularly when callability differs by group.
Key takeaway: Before testing an association in repetitive or low-mappability sequence, establish that the event is supported at the intended locus and that its genotypes are sufficiently reliable and comparably callable across the groups. If those conditions are not met, the association result is not rescued by calculating the test correctly.

Check Your Understanding

Answer each question using the distinction between a true event, a call, and the evidence available to make that call.

  1. Why can reads from a segmental duplication create misleading read-depth or breakpoint evidence for a structural variant?
  2. A read set has 750 uniquely placed reads out of 1,200 total reads in a candidate region. Calculate the uniquely placed fraction and state one reason it is not, by itself, a universal pass-or-fail result.
  3. True carrier proportions are equal in cases and controls, but cases have a higher false-positive call rate. Explain how the observed carrier proportions can nevertheless differ.
  4. Why should an uncallable sample not automatically be coded as a noncarrier?
  5. Name two region-specific checks that could inform whether a candidate event is suitable for association testing.
Clinical Biostats